A rational approach towards novel modulators of necroptosis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/53596 |
Resumo: | Necroptosis is a regulated form of necrosis that occurs in response to a cellular damage or infection. It is independent of caspases, occurring under conditions in which the classical pathway of cell death by apoptosis is inhibited. The execution of this type of cell death involves the recruitment of kinases as the RIPK1 and the RIPK3, which give rise to a complex necrosome and lead to the recruitment of the MLKL and consequent phosphorylation, triggering a necroptosis process. RIPK1 and RIPK3 are involved in a wide variety of pathologies for which they currently lack effective treatments, such as stroke, myocardial infarction or acute pancreatitis. Nec-1 was the first known inhibitor for necroptosis, acting through the blockade of RIPK1 activity. However, this presents some problems such as non-specificity for the target. As such, new inhibitors of RIPK1 have been developed, seeking to present better pharmacokinetic and pharmacodynamic properties, focusing on their stability and activity in vivo. Due to the great relevance of these new targets in the treatment of pathologies in which necroptosis is involved and based on a preliminary study of 21 Oxazol-5-(4H)-one derivatives in BV2 and L292 microglial cell lines, a lead compound, OXA 12, was found has an inhibitory activity similar to Nec-1. From OXA 12 and using the Erlenmeyer-Plöch reaction new OXAs were synthesized with the introduction of several groups. Besides these OXAs were further synthesized, altering the hippuric acid by other groups such as the hydrazones. These new compounds were subsequently used for biological evaluation. |
id |
RCAP_5d821dc7e7f3276933393efb59a8be49 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/53596 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
A rational approach towards novel modulators of necroptosisOxazol-5-(4H)-onesCell DeathNecroptosisNecrostatinDomínio/Área Científica::Engenharia e Tecnologia::Engenharia QuímicaNecroptosis is a regulated form of necrosis that occurs in response to a cellular damage or infection. It is independent of caspases, occurring under conditions in which the classical pathway of cell death by apoptosis is inhibited. The execution of this type of cell death involves the recruitment of kinases as the RIPK1 and the RIPK3, which give rise to a complex necrosome and lead to the recruitment of the MLKL and consequent phosphorylation, triggering a necroptosis process. RIPK1 and RIPK3 are involved in a wide variety of pathologies for which they currently lack effective treatments, such as stroke, myocardial infarction or acute pancreatitis. Nec-1 was the first known inhibitor for necroptosis, acting through the blockade of RIPK1 activity. However, this presents some problems such as non-specificity for the target. As such, new inhibitors of RIPK1 have been developed, seeking to present better pharmacokinetic and pharmacodynamic properties, focusing on their stability and activity in vivo. Due to the great relevance of these new targets in the treatment of pathologies in which necroptosis is involved and based on a preliminary study of 21 Oxazol-5-(4H)-one derivatives in BV2 and L292 microglial cell lines, a lead compound, OXA 12, was found has an inhibitory activity similar to Nec-1. From OXA 12 and using the Erlenmeyer-Plöch reaction new OXAs were synthesized with the introduction of several groups. Besides these OXAs were further synthesized, altering the hippuric acid by other groups such as the hydrazones. These new compounds were subsequently used for biological evaluation.Afonso, CarlosRavasco, JoãoRUNFerreira, Maria Beatriz Tomaz2020-12-01T01:30:30Z2018-11-1220182018-11-12T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/53596enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:26:27Zoai:run.unl.pt:10362/53596Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:32:39.948942Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
A rational approach towards novel modulators of necroptosis |
title |
A rational approach towards novel modulators of necroptosis |
spellingShingle |
A rational approach towards novel modulators of necroptosis Ferreira, Maria Beatriz Tomaz Oxazol-5-(4H)-ones Cell Death Necroptosis Necrostatin Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química |
title_short |
A rational approach towards novel modulators of necroptosis |
title_full |
A rational approach towards novel modulators of necroptosis |
title_fullStr |
A rational approach towards novel modulators of necroptosis |
title_full_unstemmed |
A rational approach towards novel modulators of necroptosis |
title_sort |
A rational approach towards novel modulators of necroptosis |
author |
Ferreira, Maria Beatriz Tomaz |
author_facet |
Ferreira, Maria Beatriz Tomaz |
author_role |
author |
dc.contributor.none.fl_str_mv |
Afonso, Carlos Ravasco, João RUN |
dc.contributor.author.fl_str_mv |
Ferreira, Maria Beatriz Tomaz |
dc.subject.por.fl_str_mv |
Oxazol-5-(4H)-ones Cell Death Necroptosis Necrostatin Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química |
topic |
Oxazol-5-(4H)-ones Cell Death Necroptosis Necrostatin Domínio/Área Científica::Engenharia e Tecnologia::Engenharia Química |
description |
Necroptosis is a regulated form of necrosis that occurs in response to a cellular damage or infection. It is independent of caspases, occurring under conditions in which the classical pathway of cell death by apoptosis is inhibited. The execution of this type of cell death involves the recruitment of kinases as the RIPK1 and the RIPK3, which give rise to a complex necrosome and lead to the recruitment of the MLKL and consequent phosphorylation, triggering a necroptosis process. RIPK1 and RIPK3 are involved in a wide variety of pathologies for which they currently lack effective treatments, such as stroke, myocardial infarction or acute pancreatitis. Nec-1 was the first known inhibitor for necroptosis, acting through the blockade of RIPK1 activity. However, this presents some problems such as non-specificity for the target. As such, new inhibitors of RIPK1 have been developed, seeking to present better pharmacokinetic and pharmacodynamic properties, focusing on their stability and activity in vivo. Due to the great relevance of these new targets in the treatment of pathologies in which necroptosis is involved and based on a preliminary study of 21 Oxazol-5-(4H)-one derivatives in BV2 and L292 microglial cell lines, a lead compound, OXA 12, was found has an inhibitory activity similar to Nec-1. From OXA 12 and using the Erlenmeyer-Plöch reaction new OXAs were synthesized with the introduction of several groups. Besides these OXAs were further synthesized, altering the hippuric acid by other groups such as the hydrazones. These new compounds were subsequently used for biological evaluation. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-11-12 2018 2018-11-12T00:00:00Z 2020-12-01T01:30:30Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/53596 |
url |
http://hdl.handle.net/10362/53596 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137948434694144 |